Previous close | 26.26 |
Open | 25.31 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 25.26 - 28.73 |
52-week range | 18.58 - 66.58 |
Volume | |
Avg. volume | 465 |
Market cap | 13.061M |
Beta (5Y monthly) | 1.65 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.79 |
Earnings date | 13 Feb 2024 - 19 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Thousands of pet parents, veterinarians and members of the animal health community joined Trupanion’s live event: Separating Fact, Fiction and Uncertainty on Canine Respiratory Illness SEATTLE, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today hosted an audience of thousands during a live online event, sharing proprietary data and insights in partnership with world-leading animal health experts. The live event was
In this article, we will take a look at the 12 best pet stocks to buy now. To skip our analysis of the recent market trends and activity, you can go directly to see the 5 Best Pet Stocks to Buy Now. The pet industry includes companies engaged in the provision of products and services […]
Trupanion to convene canine respiratory illness Q&A with expert veterinarian panelists live on November 30SEATTLE, Nov. 28, 2023 (GLOBE NEWSWIRE) -- With reports of a surge in respiratory illness amongst dogs in multiple states, Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, will convene a Q&A and share real-time, canine respiratory illness updates. Having covered over 3 million pets since its inception, Trupanion’s claims data contains a wealth of d